Oct 23, 2025 06:03AM

Oct 23, 2025 06:01AM

Sep 30, 2025 07:01AM

Sep 30, 2025 07:00AM

Sep 10, 2025 06:00AM

Jul 17, 2025 07:00AM

Jul 17, 2025 07:00AM NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for Continued Co-Development of Type

Jun 16, 2025 07:00AM

Apr 15, 2025 09:00AM

Mar 10, 2025 07:04AM

Mar 10, 2025 07:00AM

Feb 25, 2025 09:05AM

Jan 28, 2025 07:32AM

Jan 28, 2025 07:30AM NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

Nov 29, 2021 07:00AM

Mar 9, 2021 07:00AM

Aug 3, 2020 07:00AM

Jan 6, 2020 08:00AM

Dec 23, 2019 11:15AM

Nov 19, 2019 09:00AM

Nov 18, 2019 09:00AM Kadimastem Intends to Submit an Amendment of its ALS Phase 1/2a Clinical Trial Protocol Following Recent Positive Interim Results

Nov 11, 2019 08:00AM

Oct 7, 2019 08:00AM

Sep 24, 2019 07:10AM

Feb 27, 2019 09:00AM

Oct 9, 2018 09:00AM

Apr 26, 2018 09:00AM

Mar 13, 2018 09:00AM New Hope for ALS Patients Worldwide: Kadimastem Commences Its Clinical Trial in ALS Patients at Hadassah Medical Center After it Received Approval From the Ministry of Health

Jun 5, 2017 09:00AM

Mar 16, 2017 09:00AM

322,250 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All